And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

VRTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $42,520,712.26

Vertex Pharmaceuticals Insider Trading History Chart

Vertex Pharmaceuticals Share Price & Price History

^$393.48

▲ +0.38 (0.10%)

As of 04/18/2024 01:00 AM ET

Days: 30 | 90 | 365

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

>> Register right here

Vertex Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/26/2024	Ourania Tatsis	EVP	Sell	354	$425.70	$150,697.80	55,804
2/20/2024	Ourania Tatsis	EVP	Sell	480	$420.79	$201,979.20	59,827
2/12/2024	Amit Sachdev	EVP	Sell	3,222	$420.24	$1,354,013.28	74,364
2/12/2024	Jeffrey M. Leiden	Chairman	Sell	2,656	$419.51	$1,114,218.56	27,644
2/12/2024	Kristen Ambrose	CAO	Sell	1,374	$420.24	$577,409.76	9,676
2/12/2024	Stuart A. Arbuckle	COO	Sell	4,295	$420.24	$1,804,930.80	75,718
1/8/2024	Jeffrey M. Leiden	Chairman	Sell	6,648	$419.07	$2,785,977.36	2,423
11/6/2023	Bruce I. Sachs	Director	Sell	11,250	$385.00	$4,331,250.00	40,000
10/31/2023	Carmen Bozic	CMO	Sell	5,651	$355.92	$2,011,303.92	34,952
10/17/2023	Carmen Bozic	CMO	Sell	5,651	$373.25	$2,109,235.75	40,603
10/17/2023	Sangeeta N Bhatia	Director	Sell	243	$375.00	$91,125.00	3,901
10/16/2023	Jeffrey M. Leiden	Chairman	Sell	12,962	$374.00	$4,847,788.00	22,425
10/6/2023	Sangeeta N Bhatia	Director	Sell	242	$360.00	$87,120.00	4,144
10/3/2023	Carmen Bozic	CMO	Sell	5,651	$345.28	$1,951,177.28	46,254
10/2/2023	Jonathan Biller	EVP	Sell	610	$346.76	$211,523.60	10,569
9/19/2023	Carmen Bozic	CMO	Sell	5,651	$351.00	$1,983,501.00	51,905
8/23/2023	Ourania Tatsis	EVP	Sell	2,500	$355.00	$887,500.00	48,637
8/9/2023	David Altshuler	EVP	Sell	63	$345.51	$21,767.13	32,038
8/9/2023	Sangeeta N Bhatia	Director	Sell	242	$345.51	$83,613.42	4,386
7/17/2023	Bruce I. Sachs	Director	Sell	11,250	$356.75	$4,013,437.50	40,000
7/17/2023	Reshma Kewalramani	CEO	Sell	7,828	$355.00	$2,778,940.00	118,906
6/15/2023	Stuart A. Arbuckle	COO	Sell	8,603	$349.00	$3,002,447.00	56,556
5/30/2023	Kristen Ambrose	CAO	Sell	289	$329.82	$95,317.98	6,838
5/30/2023	Stuart A. Arbuckle	COO	Sell	82	$329.82	$27,045.24	56,556
5/8/2023	Bastiano Sanna	EVP	Sell	2,850	$350.00	$997,500.00	32,038
5/8/2023	Jeffrey M. Leiden	Chairman	Sell	1,125	$349.00	$392,625.00	35,387
5/5/2023	Bastiano Sanna	EVP	Sell	422	$350.03	$147,712.66	34,888
5/5/2023	Jeffrey M. Leiden	Chairman	Sell	879	$349.56	$307,263.24	36,512
5/2/2023	Bastiano Sanna	EVP	Sell	1,622	$350.66	$568,770.52	38,091
5/2/2023	Jeffrey M. Leiden	Chairman	Sell	6,450	$349.89	$2,256,790.50	41,899
5/2/2023	Sangeeta N Bhatia	Director	Sell	580	$348.28	$202,002.40	4,628
4/27/2023	Reshma Kewalramani	CEO	Sell	3,317	$339.08	$1,124,728.36	126,652
4/12/2023	Bastiano Sanna	EVP	Sell	7,567	$326.70	$2,472,138.90	39,713
4/12/2023	Bruce I. Sachs	Director	Sell	21,300	$326.73	$6,959,349.00	41,210
4/4/2023	Bastiano Sanna	EVP	Sell	522	$315.81	$164,852.82	47,280
3/24/2023	Charles F. Wagner, Jr.	CFO	Sell	1,768	$305.38	$539,911.84	49,611
3/17/2023	Charles F. Wagner, Jr.	CFO	Sell	2,000	$296.39	$592,780.00	51,379
3/16/2023	Bastiano Sanna	EVP	Sell	2,746	$300.59	$825,420.14	49,268
3/13/2023	Charles F. Wagner, Jr.	CFO	Sell	2,666	$293.83	$783,350.78	53,379
3/10/2023	Charles F. Wagner, Jr.	CFO	Sell	2,088	$289.61	$604,705.68	56,045
2/27/2023	Kristen Ambrose	CAO	Sell	1,207	$287.55	$347,072.85	7,303
2/27/2023	Ourania Tatsis	EVP	Sell	354	$287.48	$101,767.92	56,805
2/27/2023	Stuart A. Arbuckle	COO	Sell	5,034	$287.47	$1,447,123.98	56,556
2/22/2023	Stuart A. Arbuckle	COO	Sell	2,401	$294.33	$706,686.33	66,304
2/13/2023	Ourania Tatsis	EVP	Sell	275	$298.99	$82,222.25	65,765
2/13/2023	Stuart A. Arbuckle	COO	Sell	4,887	$298.92	$1,460,822.04	82,003
2/6/2023	David Altshuler	EVP	Sell	1,304	$306.00	$399,024.00	68,645
1/30/2023	Lloyd Carney	Director	Sell	2,700	$320.52	$865,404.00	4,150
1/27/2023	Yuchun Lee	Director	Sell	1,429	$322.03	$460,180.87	1,875
1/25/2023	Reshma Kewalramani	CEO	Sell	10,000	$315.05	$3,150,500.00	89,598
1/25/2023	Yuchun Lee	Director	Sell	4,000	$313.96	$1,255,840.00	1,875
1/23/2023	Yuchun Lee	Director	Sell	2,129	$312.02	$664,290.58	1,875
1/18/2023	Yuchun Lee	Director	Sell	442	$312.17	$137,979.14	1,875
11/7/2022	David Altshuler	EVP	Sell	1,303	$303.04	$394,861.12	36,077
10/24/2022	Sangeeta N Bhatia	Director	Sell	621	$310.00	$192,510.00	4,040
10/18/2022	Bastiano Sanna	EVP	Sell	1,791	$300.31	$537,855.21	39,192
8/15/2022	Joy Liu	SVP	Sell	3,747	$303.90	$1,138,713.30	9,605
8/15/2022	Reshma Kewalramani	CEO	Sell	11,689	$305.06	$3,565,846.34	99,598
8/15/2022	Stuart A. Arbuckle	COO	Sell	22,173	$303.93	$6,739,039.89	45,278
8/9/2022	Joy Liu	SVP	Sell	946	$300.00	$283,800.00	13,388
8/9/2022	Ourania Tatsis	EVP	Sell	1,400	$298.97	$418,558.00	46,090
8/9/2022	Stuart A. Arbuckle	COO	Sell	5,690	$300.67	$1,710,812.30	60,996
8/8/2022	Sangeeta N Bhatia	Director	Sell	621	$293.03	$181,971.63	4,661
7/29/2022	Sangeeta N Bhatia	Director	Sell	621	$278.77	$173,116.17	5,282
7/25/2022	Jeffrey M. Leiden	Chairman	Sell	132,079	$281.38	$37,164,389.02	2,423
7/19/2022	David Altshuler	EVP	Sell	17,865	$288.65	$5,156,732.25	36,077
6/24/2022	Reshma Kewalramani	CEO	Sell	11,689	$291.30	$3,405,005.70	111,153
5/4/2022	Bastiano Sanna	EVP	Sell	36	$275.09	$9,903.24	41,660
5/2/2022	Bastiano Sanna	EVP	Sell	320	$259.16	$82,931.20	41,696
5/2/2022	Charles F. Wagner, Jr.	CFO	Sell	343	$258.83	$88,778.69	42,730
5/2/2022	Sangeeta N Bhatia	Director	Sell	737	$258.94	$190,838.78	5,903
5/2/2022	Stuart A. Arbuckle	COO	Sell	306	$263.98	$80,777.88	64,760
4/29/2022	Joy Liu	SVP	Sell	120	$275.41	$33,049.20	14,334
4/25/2022	Kristen Ambrose	CAO	Sell	327	$269.55	$88,142.85	3,496
4/18/2022	Yuchun Lee	Director	Sell	2,000	$284.23	$568,460.00	1,875
4/13/2022	Jeffrey M. Leiden	Chairman	Sell	15,789	$289.04	$4,563,652.56	74,160
4/13/2022	Yuchun Lee	Director	Sell	2,000	$287.50	$575,000.00	1,875
4/11/2022	Yuchun Lee	Director	Sell	2,000	$280.30	$560,600.00	1,875
4/7/2022	Bastiano Sanna	EVP	Sell	561	$276.18	$154,936.98	42,782
4/7/2022	Yuchun Lee	Director	Sell	2,000	$274.86	$549,720.00	1,099
4/4/2022	Bastiano Sanna	EVP	Sell	562	$267.71	$150,453.02	43,343
4/4/2022	Yuchun Lee	Director	Sell	2,000	$267.72	$535,440.00	1,875
4/1/2022	Charles F. Wagner, Jr.	CFO	Sell	2,582	$264.76	$683,610.32	43,620
3/31/2022	Margaret G. McGlynn	Director	Sell	5,000	$262.27	$1,311,350.00	1,099
3/17/2022	Charles F. Wagner, Jr.	CFO	Sell	3,171	$250.15	$793,225.65
3/17/2022	Ourania Tatsis	EVP	Sell	2,833	$250.11	$708,561.63
2/25/2022	Ourania Tatsis	EVP	Sell	325	$230.95	$75,058.75
2/18/2022	Ourania Tatsis	EVP	Sell	519	$231.00	$119,889.00
2/11/2022	David Altshuler	EVP	Sell	2,297	$235.02	$539,840.94
2/2/2022	Bastiano Sanna	EVP	Sell	1,040	$250.98	$261,019.20
2/2/2022	Charles F. Wagner, Jr.	CFO	Sell	2,944	$250.07	$736,206.08
1/28/2022	Margaret G. McGlynn	Director	Sell	5,000	$241.79	$1,208,950.00
11/15/2021	Amit Sachdev	EVP	Sell	51	$187.19	$9,546.69
11/15/2021	Stuart A. Arbuckle	COO	Sell	3	$187.26	$561.78
8/19/2021	Reshma Kewalramani	CEO	Buy	10,000	$195.65	$1,956,500.00	69,511
6/2/2021	Sangeeta N. Bhatia	Director	Sell	559	$209.69	$117,216.71	5,465
5/3/2021	Bastiano Sanna	EVP	Sell	960	$218.43	$209,692.80	35,068
4/27/2021	Amit Sachdev	EVP	Sell	3,884	$216.06	$839,177.04	44,017

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

>> Register right here

SEC Filings (Institutional Ownership Changes) for Vertex Pharmaceuticals (NASDAQ:VRTX)

90.96% of Vertex Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vertex Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/18/2024	MBM Wealth Consultants LLC	2,450	$1.02M	0.4%	+3.5%	0.001%
4/18/2024	InTrack Investment Management Inc	1,544	$0.65M	0.5%	N/A	0.001%
4/18/2024	State of Michigan Retirement System	73,123	$30.57M	0.2%	+0.1%	0.028%
4/18/2024	Cullinan Associates Inc.	56,276	$23.52M	1.3%	-3.4%	0.022%
4/18/2024	Allspring Global Investments Holdings LLC	231,456	$96.75M	0.2%	+8.5%	0.090%
4/18/2024	AlphaMark Advisors LLC	5,189	$2.17M	0.8%	-8.2%	0.002%
4/18/2024	Hexagon Capital Partners LLC	138	$58K	0.0%	+74.7%	0.000%
4/18/2024	Park Place Capital Corp	792	$0.33M	0.1%	-39.0%	0.000%
4/18/2024	Claro Advisors LLC	1,363	$0.57M	0.1%	+7.7%	0.001%
4/18/2024	Miracle Mile Advisors LLC	4,470	$1.87M	0.0%	+49.4%	0.002%
4/18/2024	Little House Capital LLC	2,499	$1.05M	0.3%	+7.7%	0.001%
4/18/2024	Diversified Trust Co	1,455	$0.61M	0.0%	-25.3%	0.001%
4/18/2024	LVW Advisors LLC	613	$0.26M	0.0%	N/A	0.000%
4/18/2024	SteelPeak Wealth LLC	21,495	$8.99M	0.5%	+7.2%	0.008%
4/18/2024	Breakwater Capital Group	1,594	$0.67M	0.2%	+24.0%	0.001%
4/17/2024	D.B. Root & Company LLC	1,394	$0.58M	0.2%	+1.9%	0.001%
4/17/2024	Trilogy Capital Inc.	1,026	$0.43M	0.0%	N/A	0.000%
4/17/2024	Annapolis Financial Services LLC	64	$27K	0.0%	N/A	0.000%
4/17/2024	New Mexico Educational Retirement Board	14,800	$6.19M	0.2%	+10.4%	0.006%
4/17/2024	Founders Financial Securities LLC	1,186	$0.50M	0.1%	+18.4%	0.000%
4/17/2024	Symphony Financial Ltd. Co.	2,336	$0.98M	0.2%	+164.9%	0.001%
4/17/2024	Baker Ellis Asset Management LLC	610	$0.26M	0.0%	N/A	0.000%
4/17/2024	Grimes & Company Inc.	607	$0.25M	0.0%	+19.3%	0.000%
4/17/2024	Griffin Asset Management Inc.	8,803	$3.68M	0.4%	-1.8%	0.003%
4/17/2024	Hennion & Walsh Asset Management Inc.	7,006	$2.93M	0.2%	+7.9%	0.003%
4/16/2024	Trifecta Capital Advisors LLC	12,361	$5.17M	1.3%	+4.4%	0.005%
4/16/2024	Independence Bank of Kentucky	1,465	$0.61M	0.2%	+1,992.9%	0.001%
4/16/2024	New England Research & Management Inc.	2,835	$1.19M	0.6%	N/A	0.001%
4/16/2024	Kathmere Capital Management LLC	577	$0.24M	0.0%	+9.9%	0.000%
4/16/2024	Harbour Capital Advisors LLC	5,535	$2.27M	0.6%	+1.2%	0.002%
4/16/2024	Tevis Investment Management	875	$0.37M	0.3%	+9.9%	0.000%
4/16/2024	Atlantic Union Bankshares Corp	5,510	$2.30M	0.2%	+7.5%	0.002%
4/16/2024	Transform Wealth LLC	23,089	$9.65M	0.9%	+3.4%	0.009%
4/16/2024	180 Wealth Advisors LLC	976	$0.41M	0.1%	+42.9%	0.000%
4/16/2024	Lockerman Financial Group Inc.	534	$0.22M	0.4%	N/A	0.000%
4/16/2024	Procyon Advisors LLC	14,323	$5.99M	0.5%	+4.6%	0.006%
4/15/2024	Janiczek Wealth Management LLC	701	$0.29M	0.1%	+20.7%	0.000%
4/15/2024	Signet Financial Management LLC	8,030	$3.36M	0.5%	+1.5%	0.003%
4/15/2024	Wealthcare Advisory Partners LLC	3,218	$1.35M	0.0%	+4.6%	0.001%
4/15/2024	DGS Capital Management LLC	663	$0.28M	0.1%	N/A	0.000%
4/15/2024	Revolve Wealth Partners LLC	800	$0.33M	0.1%	+3.4%	0.000%
4/15/2024	Future Financial Wealth Managment LLC	100	$42K	0.0%	N/A	0.000%
4/15/2024	Brookstone Capital Management	2,368	$0.99M	0.0%	+11.1%	0.001%
4/15/2024	RMR Wealth Builders	3,748	$1.57M	0.2%	+26.4%	0.001%
4/15/2024	Sunbelt Securities Inc.	1,749	$0.73M	0.1%	+47.2%	0.001%
4/15/2024	Eagle Wealth Strategies LLC	964	$0.41M	0.3%	-5.4%	0.000%
4/15/2024	Constitution Capital LLC	1,050	$0.44M	0.2%	N/A	0.000%
4/15/2024	CIC Wealth LLC	3,422	$1.43M	0.4%	+27.3%	0.001%
4/15/2024	Kingswood Wealth Advisors LLC	1,693	$0.71M	0.1%	-6.0%	0.001%
4/15/2024	Security National Bank	299	$0.13M	0.0%	N/A	0.000%
4/13/2024	Evanson Asset Management LLC	566	$0.24M	0.0%	-53.8%	0.000%
4/12/2024	Dynamic Advisor Solutions LLC	5,706	$2.39M	0.1%	+143.5%	0.002%
4/12/2024	Riverview Trust Co	194	$81K	0.1%	N/A	0.000%
4/12/2024	Gateway Investment Advisers LLC	69,502	$29.05M	0.3%	-6.1%	0.027%
4/12/2024	Capital Advisors Wealth Management LLC	1,742	$0.73M	0.2%	N/A	0.001%
4/12/2024	Strategic Planning Group LLC	3,074	$1.29M	0.3%	+4.8%	0.001%
4/12/2024	Global Assets Advisory LLC	330,077	$137.98M	0.4%	N/A	0.128%
4/12/2024	AdvisorNet Financial Inc	1,186	$0.50M	0.0%	+4.7%	0.000%
4/12/2024	Global Trust Asset Management LLC	832	$0.35M	0.1%	-49.9%	0.000%
4/12/2024	Anderson Hoagland & Co.	21,173	$8.42M	0.9%	+27.0%	0.008%
4/11/2024	Ballentine Partners LLC	4,878	$2.04M	0.0%	+6.8%	0.002%
4/11/2024	RDA Financial Network	2,282	$0.95M	0.3%	+33.2%	0.001%
4/11/2024	Opal Wealth Advisors LLC	134	$56K	0.0%	N/A	0.000%
4/11/2024	Cooper Financial Group	3,627	$1.52M	0.2%	+12.4%	0.001%
4/11/2024	Contravisory Investment Management Inc.	1,529	$0.64M	0.1%	-1.9%	0.001%
4/11/2024	Bangor Savings Bank	6,314	$2.64M	0.3%	-6.1%	0.002%
4/11/2024	MJP Associates Inc. ADV	543	$0.23M	0.0%	N/A	0.000%
4/11/2024	Private Harbour Investment Management & Counsel LLC	5,403	$2.26M	2.4%	-0.6%	0.002%
4/11/2024	17 Capital Partners LLC	940	$0.39M	0.3%	-51.2%	0.000%
4/11/2024	Gulf International Bank UK Ltd	22,522	$9.41M	0.2%	+6.4%	0.009%
4/11/2024	CHURCHILL MANAGEMENT Corp	46,176	$19.30M	0.2%	-0.8%	0.018%
4/11/2024	RFG Advisory LLC	1,415	$0.59M	0.0%	+30.5%	0.001%
4/10/2024	Triangle Securities Wealth Management	1,850	$0.77M	0.2%	-2.3%	0.001%
4/10/2024	Fragasso Group Inc.	1,329	$0.56M	0.0%	-31.1%	0.001%
4/10/2024	Atwood & Palmer Inc.	54,133	$22.63M	1.7%	+3.1%	0.021%
4/10/2024	Partnership Wealth Management LLC	1,746	$0.73M	0.5%	-26.1%	0.001%
4/10/2024	Park Avenue Securities LLC	14,239	$5.95M	0.1%	+8.3%	0.006%
4/10/2024	KMG Fiduciary Partners LLC	543	$0.23M	0.0%	+10.1%	0.000%
4/10/2024	First National Bank of Mount Dora Trust Investment Services	6,609	$2.76M	0.7%	N/A	0.003%
4/10/2024	Wedmont Private Capital	3,058	$1.24M	0.1%	+7.5%	0.001%
4/10/2024	Banque Cantonale Vaudoise	1,206	$0.50M	0.0%	-78.7%	0.000%
4/10/2024	Czech National Bank	45,342	$18.95M	0.2%	+0.4%	0.018%
4/10/2024	Fulton Bank N.A.	4,064	$1.70M	0.1%	-1.1%	0.002%
4/10/2024	Perpetual Ltd	197,351	$82.50M	0.8%	-5.0%	0.076%
4/9/2024	Alaska Permanent Fund Corp	26,847	$11.22M	0.2%	-11.0%	0.010%
4/9/2024	Massmutual Trust Co. FSB ADV	863	$0.36M	0.0%	+25.4%	0.000%
4/9/2024	Rise Advisors LLC	156	$65K	0.0%	+3,020.0%	0.000%
4/9/2024	Mather Group LLC.	3,537	$1.44M	0.0%	-2.9%	0.001%
4/5/2024	First Hawaiian Bank	3,642	$1.52M	0.0%	-17.7%	0.001%
4/5/2024	GAMMA Investing LLC	2,168	$0.91M	0.2%	+8.1%	0.001%
4/5/2024	Capital Market Strategies LLC	1,157	$0.48M	0.4%	+21.8%	0.000%
4/5/2024	Los Angeles Capital Management LLC	132,714	$55.48M	0.2%	-66.0%	0.051%
4/5/2024	CWM LLC	6,040	$2.53M	0.0%	+8.5%	0.002%
4/4/2024	Orrstown Financial Services Inc.	516	$0.22M	0.1%	N/A	0.000%
4/3/2024	Strategic Advocates LLC	5,558	$2.32M	0.9%	N/A	0.002%
4/2/2024	M&R Capital Management Inc.	525	$0.22M	0.1%	+134.4%	0.000%
4/1/2024	Appleton Partners Inc. MA	1,846	$0.77M	0.1%	-10.6%	0.001%
3/29/2024	Kapitalo Investimentos Ltda	588	$0.24M	0.0%	N/A	0.000%
3/26/2024	HighPoint Advisor Group LLC	3,588	$1.49M	0.1%	N/A	0.001%
3/22/2024	PNC Financial Services Group Inc.	76,696	$31.21M	0.0%	+3.3%	0.030%

Data available starting January 2016

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people with CF for 6 years of age or older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 year or older who have CF with ivacaftor. The company's pipeline includes VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1 clinical trial; VX-548, a non-opioid medicine for the treatment of acute and neuropathic pain which is in Phase 3 clinical trial; Exa-cel, for the treatment of sickle cell disease and transfusion-dependent beta thalassemia which is in Phase 2/3 clinical trial. In addition, it provides inaxaplin for the treatment of APOL1-mediated focal segmental glomerulosclerosis and co-morbidities, such as hypertension which is in single Phase 2/3; VX- 880 and VX-264, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-970, which is in Phase 2 clinical trial for the treatment of cancer; and VX-803 and VX-984 for treatment of cancer in Phase 1 clinical trial. Further, it sells the products to specialty pharmacy and specialty distributors in the United States, as well as retail pharmacies, hospitals, and clinics. Additionally, the company has collaborations with CRISPR Therapeutics AG.; Moderna, Inc.; Entrada Therapeutics, Inc.; Arbor Biotechnologies, Inc.; Mammoth Biosciences, Inc.; and Verve Therapeutics., as well as collaborations with Tevard Biosciences to develop novel tRNA-based therapies for duchenne muscular dystrophy. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $393.48

$391.02

$396.14

50 Day Range

MA: $414.17

$393.10

$433.48

52 Week Range

Now: $393.48

$316.43

$448.40

Volume

948,866 shs

Average Volume

862,071 shs

Market Capitalization

$101.70 billion

P/E Ratio

28.33

Dividend Yield

N/A

Beta

0.35

Who are the company insiders with the largest holdings of Vertex Pharmaceuticals?: Vertex Pharmaceuticals' top insider shareholders include:
Reshma Kewalramani (CEO)
Stuart A Arbuckle (COO)
Amit Sachdev (EVP)
David Altshuler (EVP)
Ourania Tatsis (EVP)
Charles F Wagner Jr (CFO)
Carmen Bozic (CMO)
Bastiano Sanna (EVP)
Jeffrey M Leiden (Chairman)
Bruce I Sachs (Director)
Joy Liu (SVP)
Jonathan Biller (EVP)
Kristen Ambrose (CAO)
Sangeeta N Bhatia (Director)
Lloyd Carney (Director)
Yuchun Lee (Director)
Learn More about top insider investors at Vertex Pharmaceuticals.
Who are the major institutional investors of Vertex Pharmaceuticals?: Vertex Pharmaceuticals' top institutional investors include:
Sumitomo Mitsui Trust Holdings Inc. — 0.28%
Global Assets Advisory LLC — 0.13%
Allspring Global Investments Holdings LLC — 0.09%
Perpetual Ltd — 0.08%
Los Angeles Capital Management LLC — 0.05%
State of Michigan Retirement System — 0.03%
Learn More about top institutional investors of Vertex Pharmaceuticals stock.
Which major investors are selling Vertex Pharmaceuticals stock?: Within the previous quarter, VRTX stock was sold by these institutional investors:
Los Angeles Capital Management LLC
Perpetual Ltd
Gateway Investment Advisers LLC
Banque Cantonale Vaudoise
Alaska Permanent Fund Corp
Cullinan Associates Inc.
17 Capital Partners LLC
Global Trust Asset Management LLC
In the last year, company insiders that have sold Vertex Pharmaceuticals company stock include:
Reshma Kewalramani (CEO)
Stuart A Arbuckle (COO)
Amit Sachdev (EVP)
David Altshuler (EVP)
Ourania Tatsis (EVP)
Charles F Wagner Jr (CFO)
Carmen Bozic (CMO)
Bastiano Sanna (EVP)
Jeffrey M Leiden (Chairman)
Bruce I Sachs (Director)
Joy Liu (SVP)
Jonathan Biller (EVP)
Learn More investors selling Vertex Pharmaceuticals stock.
Which major investors are buying Vertex Pharmaceuticals stock?: During the previous quarter, VRTX stock was acquired by institutional investors including:
Global Assets Advisory LLC
Allspring Global Investments Holdings LLC
Sumitomo Mitsui Trust Holdings Inc.
First National Bank of Mount Dora Trust Investment Services
Strategic Advocates LLC
Anderson Hoagland & Co.
Dynamic Advisor Solutions LLC
New England Research & Management Inc.

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

>> Register right here

VRTX Insider Trading

Vertex Pharmaceuticals Insider Trading History Chart

Vertex Pharmaceuticals Share Price & Price History

Vertex Pharmaceuticals Insider Trading History

SEC Filings (Institutional Ownership Changes) for Vertex Pharmaceuticals (NASDAQ:VRTX)

Institutional Buying and Selling by Quarter

Vertex Pharmaceuticals Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Vertex Pharmaceuticals?

Who are the major institutional investors of Vertex Pharmaceuticals?

Which major investors are selling Vertex Pharmaceuticals stock?

Which major investors are buying Vertex Pharmaceuticals stock?